Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Lisa Kamen"'
Autor:
Susan Hutchinson, Kathleen Mullin, Jelena Pavlovic, Richard Lipton, Christopher Jensen, Alexandra Thiry, Lisa Kamen, Robert Croop
Publikováno v:
Tuesday, April 25.
Autor:
Jelena Pavlovic, Ira Turner, Paul Winner, Richard Lipton, Gilbert L’Italien, Christopher Jensen, Alexandra Thiry, Lisa Kamen, Robert Croop
Publikováno v:
Wednesday, April 26.
Autor:
Richard Lipton, David Kudrow, Timothy Smith, Jessica Ailani, Peter Goadsby, Lisa Kamen, Alexandra Thiry, Christopher Jensen, Robert Croop
Publikováno v:
Wednesday, April 26.
Autor:
Susan Hutchinson, Jelena Pavlovic, Jessica Ailani, Kathleen Mullin, Robert Croop, Alexandra Thiry, Beth Morris, Lisa Kamen, Chandra Abbott
Publikováno v:
Tuesday, April 25.
Autor:
Kathleen Mullin, Jelena Pavlovic, Susan Hutchinson, Richard Lipton, Christopher Jensen, Alexandra Thiry, Lisa Kamen, Robert Croop
Publikováno v:
Wednesday, April 26.
Autor:
Teresa E. Baker, Robert Croop, Lisa Kamen, Patty Price, David A. Stock, Andrea Ivans, Rajinder Bhardwaj, Matt S. Anderson, Jennifer Madonia, Joseph Stringfellow, Richard Bertz, Vladimir Coric, Thomas W. Hale
Publikováno v:
Breastfeeding Medicine. 17:277-282
Autor:
David Kudrow, Lisa Kamen, Vladimir Coric, Charles M. Conway, Richard B. Lipton, Elyse Stock, David A. Stock, Peter J. Goadsby, Robert Croop
Publikováno v:
Lancet (London, England). 397(10268)
Summary Background Rimegepant is a calcitonin gene-related peptide receptor antagonist that has shown efficacy and safety in the acute treatment of migraine. We aimed to compare the efficacy of rimegepant with placebo for preventive treatment of migr
Autor:
William H. Carson, Lisa Kamen, Robert D. McQuade, Ronald N. Marcus, Michael G. Aman, Randall Owen, George Manos
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 48:1110-1119
To evaluate the short-term efficacy and safety of aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.Two hundred eighteen children and adolescents (aged 6-17 years) with a diagnosis of autistic disorder,
Autor:
Lisa Kamen, William H. Carson, Raymond Mankoski, Ronald N. Marcus, Patricia K. Corey-Lisle, George Manos, Michael G. Aman, Randall Owen, Robert D. McQuade
Publikováno v:
Journal of child and adolescent psychopharmacology. 21(3)
To report the long-term efficacy of aripiprazole in the treatment of irritability in children and adolescents (ages 6-17 years) with autistic disorder.This was a 52-week, open-label, flexible-dose (2-15 mg/day) study of aripiprazole for the treatment
Autor:
Raymond Mankoski, Ronald N. Marcus, Robert L. Findling, William H. Carson, Lisa Kamen, George Manos, Robert D. McQuade, Randall Owen
Publikováno v:
The Journal of clinical psychiatry. 72(9)
Objective Evaluate the long-term safety and tolerability of aripiprazole in the treatment of irritability in pediatric subjects (6-17 years) with autistic disorder. Method A 52-week, open-label, flexibly dosed (2-15 mg/d) study of the safety and tole